May 16, 2016—Safety-net hospitals rely heavily on 340B drug discount program savings to pay for free and discounted drugs, clinical services, and other vital benefits to vulnerable patients, a new report from the hospital group 340B Health concludes. … [Read more...]
340B Recertification for Title X Centers Begins May 11
Hospitals will go through process later this yearMay 10, 2016—Annual recertification of eligibility for 340B drug discounts for Title X family planning centers begins tomorrow, May 11 and ends on June 8, the Health Resources and Services Administration announced today. … [Read more...]
Genentech Owes 340B Providers Refunds for Overcharges
Notice covers 25 products sold between 1Q 2012 and 2Q 2013May 3, 2016—Genentech is offering 340B providers refunds for charges above statutorily defined ceiling prices on 25 products sold from the first quarter of 2012 to the second quarter of 2013. … [Read more...]
CMS Final Rule Addresses Using 340B Drugs in Medicaid Managed Care
States must establish procedures for preventing duplicate discountsApril 29, 2016—States must require Medicaid managed care organizations to establish procedures to exclude utilization data for drugs subject to 340B drug discounts from the utilization reports submitted to states for purposes of collecting Medicaid drug rebates, the Centers for Medicare & Medicaid Services says in a new final regulation. States also can opt instead to … [Read more...]
Protect 340B, Cardiologist Asks Congress at Hearing on Drug Prices
"Can’t think of a worse time to be thinking of cutting a program designed to make drugs more affordable"April 28, 2016—The chief clinical officer of one of Indiana's largest safety-net hospitals implored Congress to protect the 340B drug discount program in light of "hyperinflation in pharmaceutical pricing." "I understand that some are calling for significant restructuring of the 340B program," said cardiologist Dr. Richard Fogel of St. Vincent health system in written … [Read more...]
Broad-Based Coalition Has Plan to Fix “Broken” Prescription Drug Market
Coalition for Sustainable Rx Pricing calls for transparency, competition, and valueApril 25, 2016—A broad coalition of healthcare providers, payers, and citizens groups today issued a multi-point plan "aimed at fixing the broken prescription drug market" by emphasizing transparency, competition, and value. … [Read more...]
HHS Reopens Comments for 30 Days on 340B Pricing and Monetary Penalty Regulation
Wants input on penny pricing, 340B prices for new drugs, knowing-and-intentional standard for penaltiesApril 18, 2016—The Department of Health and Human Services is giving 340B stakeholders an extra 30 days, until May 19, to comment on three aspects of its proposed 340B program rule setting standards for calculating ceiling prices and implementing civil monetary penalties for drugmakers that knowingly and intentionally overcharge for 340B drugs. … [Read more...]